carbapenems has been researched along with Necrotizing Pyelonephritis in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 14 (56.00) | 24.3611 |
| 2020's | 7 (28.00) | 2.80 |
| Authors | Studies |
|---|---|
| Critchley, IA; Dane, A; Eckburg, PB; Jain, A; Keutzer, T; Kwak, H; Melnick, D; Moore, G; Muir, L; Phelan, AM; Talley, AK; Walpole, S | 1 |
| Gueneau, R; Henry, B | 1 |
| Bhavnani, SM; Ganesan, H; Gupta, VK; Melnick, D; Rubino, CM; Safir, MC; Talley, AK | 1 |
| Cao, SS; Cui, B; Cui, F; Cui, J; Fan, BY; Fan, TT; Guan, Y; Ji, B; Li, MY; Li, SR; Wang, JW; Wang, L; Yan, CY; Zhang, W | 1 |
| David, SSB; Maor, Y; Schwartz, O; Yossepowitch, O; Zohar, I | 1 |
| Decousser, JW; Fihman, V; Lepeule, R; Royer, G; Woerther, PL | 1 |
| Lai, CC; Wang, JH | 1 |
| Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK | 1 |
| Angoulvant, F; Bontemps, S; Cohen, R; Dessein, R; Dubos, F; Lagree, M; Madhi, F; Martinot, A | 1 |
| Asadi Karam, MR; Bouzari, S; Habibi, M; Shahbazi, S; Talebi, A | 1 |
| Growcott, EJ; Nguyen, P; Pulse, ME; Weiss, WJ | 1 |
| Delacour, H; Janvier, F; Jeannot, K; Mérens, A; Rapp, C; Robert-Nicoud, M; Tessé, S | 1 |
| Bille, E; Emirian, A; Groh, M; Guet-Revillet, H; Join-Lambert, O; Jullien, V; Nebbad-Lechani, B; Weiss, E; Zahar, JR | 1 |
| Hong, MT; Seifert, CF | 1 |
| Bonomo, RA; Garber, K; Harris, PN; Hecker, M; Hurless, K; Jacobs, MR; Kalayjian, RC; Khatri, A; Naeger Murphy, N; Osborn, M; Paterson, DL; Perez, F; Rudin, SD; Salata, RA; van Duin, D; Wiest, P | 1 |
| Han, SB; Jeong, DC; Kang, JH; Lee, SC; Lee, SY | 1 |
| Armstrong, J; Gasink, LB; Huang, X; Newell, P; Sobel, JD; Stone, GG; Wagenlehner, FM; Yates, K | 1 |
| Naber, KG; Redman, R; Wagenlehner, C; Wagenlehner, FM; Weidner, W | 1 |
| Hedrich, D; Kaniga, K; Kotey, P; Llorens, L; Naber, KG; Redman, R | 1 |
| Furuya, R; Hashimoto, J; Hashimoto, K; Hotta, H; Ichihara, K; Igarashi, M; Kurimura, Y; Miyamoto, S; Miyao, N; Tachiki, H; Taguchi, K; Takagi, Y; Takahashi, S; Takeyama, K; Tsukamoto, T; Uchida, K; Yanase, M | 1 |
| Lin, R; Nandy, P; Samtani, MN | 1 |
| Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N | 1 |
| Damiao, R; Davies, T; Kaniga, K; Kotey, P; Naber, KG; Redman, R | 1 |
| Doi, A; Harada, S; Iwata, K; Kamiya, T; Shimada, T | 1 |
| Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
6 trial(s) available for carbapenems and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Carbapenems; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Pyelonephritis; Urinary Tract Infections | 2022 |
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
Topics: Adult; Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Doripenem; Drug Combinations; Female; Humans; Male; Middle Aged; Pyelonephritis; Urinary Tract Infections | 2016 |
Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Pyelonephritis; Urinary Tract Infections | 2009 |
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pyelonephritis; Urinary Tract Infections | 2009 |
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult | 2010 |
Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.
Topics: Aged; Anti-Infective Agents, Urinary; Carbapenems; Doripenem; Double-Blind Method; Female; Genotype; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Urinary Tract Infections | 2010 |
19 other study(ies) available for carbapenems and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Which trial do we need? Piperacillin-tazobactam compared with a carbapenem for treatment of graft pyelonephritis caused by extended spectrum β-lactamase-producing Enterobacteriaceae.
Topics: beta-Lactamases; Carbapenems; Enterobacteriaceae; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis | 2023 |
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
Topics: Administration, Oral; Anti-Bacterial Agents; Carbapenems; Humans; Monobactams; Prodrugs; Pyelonephritis; Urinary Tract Infections | 2023 |
Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing
Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections | 2023 |
Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections | 2020 |
Emergence of Resistance to Carbapenems Should Not Be Considered the Only Marker of Good Practices in Antibiotic Stewardship.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamases; Carbapenems; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis | 2020 |
Is Piperacillin-Tazobactam Really Comparable to Carbapenem for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?
Topics: beta-Lactamases; Carbapenems; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis | 2020 |
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Cystitis; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospitals, University; Humans; Inappropriate Prescribing; Male; Practice Patterns, Physicians'; Pyelonephritis; Retrospective Studies; Secondary Care Centers; Surveys and Questionnaires; Urinary Tract Infections | 2018 |
Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Quinolones; Uropathogenic Escherichia coli; Virulence; Virulence Factors; Young Adult | 2018 |
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Monobactams; Pyelonephritis | 2019 |
Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Female; France; Humans; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Sequence Analysis, DNA | 2013 |
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefoxitin; Drug Administration Schedule; Drug Dosage Calculations; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Models, Statistical; Pyelonephritis; Urinary Tract Infections | 2014 |
Clinical Impact of Discordant Prescribing of Fluoroquinolones and Alternative Treatments in Escherichia coli Pyelonephritis.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Treatment Outcome | 2016 |
Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Community-Acquired Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Pregnancy; Pyelonephritis | 2015 |
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pyelonephritis; Republic of Korea; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Efficacy of treatment with carbapenems and third-generation cephalosporins for patients with febrile complicated pyelonephritis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Female; Fever; Humans; Male; Middle Aged; Pyelonephritis; Urine | 2009 |
New Delhi metallo-beta-lactamase from traveler returning to Canada.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine | 2011 |
The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefmetazole; Culture Media; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Pyelonephritis; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine | 2013 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |